Osaic Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-60
Closed -$6K 7367
2022
Q3
$6K Sell
60
-80
-57% -$3.89K ﹤0.01% 6288
2022
Q2
$2K Sell
140
-90
-39% -$4.59K ﹤0.01% 6913
2022
Q1
$5K Buy
+230
New +$11.9K ﹤0.01% 6495
2020
Q3
Sell
-269
Closed -$39K 6357
2020
Q2
$39K Buy
269
+258
+2,345% +$8.77K ﹤0.01% 4369
2020
Q1
$1K Buy
+11
New +$375 ﹤0.01% 5893

Other funds holding PFE

Osaic Holdings's PFE Position: Q1 2026 in Review

Osaic Holdings increased its Pfizer (PFE) stake by 16% in Q1 2026, buying an estimated $8.72M and bringing the position to 2,374,689 shares worth $66.7M. The position accounts for 0.1% of the portfolio, ranked #215.

Osaic Holdings first reported a position in PFE in Q1 2020 and has held it in 25 quarters since. The position peaked at $132M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Osaic Holdings held 2,374,689 shares of Pfizer worth $66.7M as of Q1 2026.
  • Osaic Holdings bought 327,529 Pfizer shares in Q1 2026, an estimated $8.72M.
  • Pfizer made up 0.1% of Osaic Holdings's portfolio in Q1 2026, its #215 holding.
  • Osaic Holdings first reported a position in Pfizer in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Pfizer position peaked at $132M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.